0001127602-23-026007.txt : 20231017 0001127602-23-026007.hdr.sgml : 20231017 20231017171045 ACCESSION NUMBER: 0001127602-23-026007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reidy Christopher R CENTRAL INDEX KEY: 0001290907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10315 FILM NUMBER: 231330311 MAIL ADDRESS: STREET 1: ONE ADP BLVD CITY: ROSELAND STATE: NJ ZIP: 07068 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Encompass Health Corp CENTRAL INDEX KEY: 0000785161 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 630860407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-967-7116 MAIL ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH CORP DATE OF NAME CHANGE: 19950113 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-10-16 0000785161 Encompass Health Corp EHC 0001290907 Reidy Christopher R 20 HAMPTON ROAD CRANFORD NJ 07016 1 0 Encompass Health Common Stock 2023-10-16 4 A 0 16 0 A 8536 D Encompass Health Common Stock 2023-10-17 4 A 0 4 64.50 A 8540 D Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their director fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the dividend of $0.15 per share paid on October 16, 2023. /s/ Patrick Darby, attorney-in-fact for Christopher R. Reidy 2023-10-17